Biogen (BIIB) EV to FCF (2009 - 2026)
Biogen (BIIB) posted EV to FCF of 75.09 for Q2 2026, up 95.88% on a QoQ basis from 38.34 in Q1 2026, and down 35.58% year-over-year from 116.56 in Q2 2025.
Analysis
Biogen (BIIB) EV to FCF (2009 - 2026) Analysis & Trends
Biogen has reported EV to FCF for 18 years, with the latest figure at 75.09 in Q2 2026.
- On a quarterly basis, EV to FCF fell 35.58% year-over-year to 75.09 in Q2 2026; TTM through Jun 2026 was 11.36, a 43.61% increase from a year earlier, with the FY2025 full-year figure at 10.74, up 46.7% from the prior year.
- EV to FCF was 75.09 for Q2 2026 at Biogen, up from 38.34 in the prior quarter.
- The five-year high for EV to FCF was 260.53 in Q1 2022, with the low at 691.57 in Q4 2023.
- Average EV to FCF over 5 years is 17.14, with a median of 54.75 recorded in 2024.
- The largest YoY upside for EV to FCF was 345.45% in 2022 against a maximum downside of 433.84% in 2022.
- Over 5 years, EV to FCF stood at 133.8 in 2022, then tumbled by 416.89% to 691.57 in 2023, then surged by 103.99% to 27.61 in 2024, then jumped by 70.43% to 47.05 in 2025, then jumped by 59.6% to 75.09 in 2026.
- The last three EV to FCF figures came in at 75.09 (Q2 2026), 38.34 (Q1 2026), and 47.05 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | BioNTech SE | 26.24 Bn | 12.58 Bn | 10.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 75.09 |
| Mar 31, 2026 | 38.34 |
| Dec 31, 2025 | 47.05 |
| Sep 30, 2025 | 13.53 |
| Jun 30, 2025 | 116.56 |
| Mar 31, 2025 | 78.54 |
| Dec 31, 2024 | 27.61 |
| Sep 30, 2024 | 29.48 |
| Jun 30, 2024 | 53.79 |
| Mar 31, 2024 | 59.77 |
| Dec 31, 2023 | -691.57 |
| Sep 30, 2023 | 67.44 |
| Jun 30, 2023 | 84.54 |
| Mar 31, 2023 | 90.54 |
| Dec 31, 2022 | -133.80 |
| Sep 30, 2022 | 55.70 |
| Jun 30, 2022 | 35.43 |
| Mar 31, 2022 | 260.53 |
| Dec 31, 2021 | 40.08 |
| Sep 30, 2021 | 51.18 |